79222-83-6

Upstream product

• 2166-31-6 6-phenylpyridazin-3(2H)-one 
• 140-88-5 ethyl acrylate 
• 539-74-2 Ethyl 3-bromopropionate 

Downstream Products

• 73402-26-3 3-[6-phenyl-pyridazin-3(2H)-one-2-yl]-propanoic acid 
• 1426561-22-9 N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-(6-oxo-3-phenylpyridazin-1(6H)-yl)propanamide 
• 346407-31-6 N₁-(4-amino-3-methyl-1-propyl-uracil-5-yl)-3-[6-phenyl-pyridazin-3(2H)-one-2-yl]-propanamide 
• 346407-21-4 N₁-(4-amino-1,3-dimethyl-uracil-5-yl)-3-[6-phenyl-pyridazin-3(2H)-one-2-yl]-propanamide 

Relevant academic research and scientific papers

Synthesis of antipyrine/pyridazinone hybrids and investigation of their in vivo analgesic and anti-inflammatory activities

Eleven antipyrine/pyridazinone hybrids were synthesized and evaluated for their in vivo analgesic and anti-inflammatory activities by p-benzoquinone- induced writhing test and carrageenan-induced paw edema model, respectively. The test results indicated t

Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists

A series of 8-substituted xanthines were synthesized and their affinity in vitro towards A1, A2A-adenosine receptors was evaluated by radioligand receptor binding assays. All compounds showed a greater affinity and selectivity toward